1,1,1,3,3,3-Hexafluoro-2-propanol → HCID 89682770, compound
Reaction equation
ClC(Cl)(O[C:5](=[O:11])OC(Cl)(Cl)Cl)Cl.[F:13][C:14]([F:22])([F:21])[CH:15]([OH:20])[C:16]([F:19])([F:18])[F:17].C(N(CC)C(C)C)(C)C.[CH3:32][C:33]1[C:38]([CH2:39][N:40]2[CH2:45][CH2:44][NH:43][CH2:42][CH2:41]2)=[CH:37][CH:36]=[C:35]([C:46]2[CH:51]=[CH:50][CH:49]=[CH:48][C:47]=2[CH3:52])[N:34]=1>O.ClCCl>[CH3:32][C:33]1[C:38]([CH2:39][N:40]2[CH2:41][CH2:42][N:43]([C:5]([O:20][CH:15]([C:16]([F:19])([F:18])[F:17])[C:14]([F:22])([F:21])[F:13])=[O:11])[CH2:44][CH2:45]2)=[CH:37][CH:36]=[C:35]([C:46]2[CH:51]=[CH:50][CH:49]=[CH:48][C:47]=2[CH3:52])[N:34]=1Participants
Procedure
A 100 mL round-bottom flask, was charged with triphosgene (63.0 mg, 0.200 mmol, 0.30 equiv), dichloromethane (10 mL), 1,1,1,3,3,3-hexafluoropropan-2-ol (119 mg, 0.710 mmol, 1.00 equiv). N,N-Di-isopropylethylamine (174 mg, 1.35 mmol, 2.00 equiv) was added drop-wise. The resulting solution was stirred for 2 h at room temperature. 1-[[2-Methyl-6-(2-methylphenyl)pyridin-3-yl]methyl]piperazine (200 mg, 0.710 mmol, 1.00 equiv) was added. The resulting solution was stirred overnight at room temperature and then diluted with water (10 mL). The resulting mixture was extracted with dichloromethane (3×10 mL) and the organic layers were combined, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude product (230 mg) was purified by preparative HPLC using the following gradient conditions: 20% CH3CN/80% Phase A increasing to 80% CH3CN over 10 min, then to 100% CH3CN over 0.1 min, holding at 100% CH3CN for 1.9 min, then reducing to 20% CH3CN over 0.1 min, and holding at 20% for 1.9 min, on a Waters 2767-5 Chromatograph. Column: Xbridge Prep C18, 19*150 mm 5 um; Mobile phase: Phase A: aqueous NH4HCO3 (0.05%); Phase B: CH3CN; Detector, UV220 & 254 nm. Purification resulted in 146.2 mg (43% yield) of 1,1,1,3,3,3-hexafluoropropan-2-yl 4-[[2-methyl-6-(2-methylphenyl)pyridin-3-yl]methyl]piperazine-1-carboxylate as a off-white solid. 1H NMR 300 MHz (CDCl3) δ 7.62 (d, J=7.8 Hz, 1H), 7.37-7.40 (m, 1H), 7.31-7.35 (m, 3H), 7.19-7.28 (m, 1H), 5.72-5.80 (m, 1H), 3.56-3.59 (m, 6H), 2.64 (s, 3H), 2.51-2.56 (m, 4H), 2.36 (s, 3H). LCMS (ESI, m/z): 476 [M+H]+.
Workup
- stirringThe resulting solution was stirred overnight at room temperature
- extractionThe resulting mixture was extracted with dichloromethane (3×10 mL)
- dry with materialdried over anhydrous sodium sulfate
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customThe crude product (230 mg) was purified by preparative HPLC
- wait20% CH3CN/80% Phase A increasing to 80% CH3CN over 10 min
- waitto 100% CH3CN over 0.1 min
- waitholding at 100% CH3CN for 1.9 min
- waitreducing to 20% CH3CN over 0.1 min
- waitholding at 20% for 1.9 min, on a Waters 2767-5 Chromatograph
- customPurification
Sources & evidence
- ORD record
- ord-efbf8fcd2f5b47308223aa399c4f6edf
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09133148B2
Reaction notes
Loading…